Why We Invest Where We Invest
Our investment thesis isn't about chasing sectors — it's about finding opportunities where operational expertise and capital can create lasting value.
By Hekla Ventures
The Hekla Thesis
Most holding companies pick a lane. Real estate or tech. Healthcare or services. We've deliberately chosen a different path — not because we lack focus, but because we've found that the same principles drive success across very different sectors.
Every Hekla investment shares three characteristics:
The problem is real and urgent. We don't invest in nice-to-haves. Rare disease patients need therapies. Working families need affordable homes. Small businesses need tools to compete. When the problem is real, demand is durable.
Operational expertise is the unlock. We look for opportunities where knowing how to build, launch, and scale is the difference between a good idea and a great business. Capital alone isn't enough — the companies in our portfolio benefit from hands-on commercial and strategic leadership.
Impact and returns are aligned. We've found that businesses solving meaningful problems build deeper moats. Manufactured housing communities that invest in resident well-being have lower turnover. Therapeutics that serve unmet needs command premium positioning. AI tools that genuinely save small businesses time generate organic word-of-mouth that paid marketing can't replicate.
What This Looks Like in Practice
When we evaluate a biotech consulting engagement, we ask: can our commercial experience materially change this company's trajectory? When we acquire a manufactured housing community, we ask: can we improve both resident outcomes and financial performance simultaneously? When we build an AI tool, we ask: does this solve a problem that a real person described to us in plain language?
The answers to these questions have led us to a portfolio that spans rare disease therapeutics, affordable housing in Maine, AI-powered back-office tools for plumbers and HVAC technicians, and sustainable energy ventures. On paper, these look unrelated. In practice, they're all expressions of the same thesis.
Looking Ahead
We're still early. The portfolio is growing, the thesis is being refined by real-world feedback, and we're learning every day. But the core conviction hasn't changed: invest in real problems, bring operational excellence, and build businesses that create value for everyone they touch.